Colleen Sweeney - Concepedia

Author

Colleen Sweeney

University of California, Davis ORCID

Also Known As

C Sweeney, C. A. Sweeney, C. Sweeney, COLLEEN SWEENEY, Colleen A Sweeney, Colleen A. Sweeney, Colleen Sweeney

179

Publications

5.9K

Citations

H-Index

127

Concepts

All Affiliations

University of California, Davis UC Davis Comprehensive Cancer Center University of California Davis Medical Center Leibniz Institute of Environmental Medicine Oklahoma State University

About

Colleen Sweeney is an author at University of California, Davis specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	23	1.7K
2	Engineering	4	4	230
3	Natural Sciences	4	4	348
4	Health Sciences	2	2	54
5	Arts	1	1	50

Colleen Sweeney

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells David L. Shattuck, Jamie K. Miller, Kermit L. Carraway, Cancer Research	2008	444
The Natural History of Spondylolysis and Spondylolisthesis William Beutler, Bruce E. Fredrickson, Albert Murtland, Spine	2003	291
Identification of Nuclear Genes Encoding Chloroplast-Localized Proteins Required for Embryo Development in Arabidopsis Nicole Bryant, John P. Lloyd, Colleen Sweeney, PLANT PHYSIOLOGY	2010	238
The Leucine-rich Repeat Protein LRIG1 Is a Negative Regulator of ErbB Family Receptor Tyrosine Kinases Melanie B. Laederich, Melanie Funes-Duran, Lily Yen, Journal of Biological Chemistry Developmental BiologySignal TransductionNegative RegulatorCell RegulationGrowth Factor	2004	237
Recurrent Laryngeal Nerve Injury With Anterior Cervical Spine Surgery William Beutler, Colleen Sweeney, Patrick J. Connolly Spine	2001	206
Stabilization of the E3 Ubiquitin Ligase Nrdp1 by the Deubiquitinating Enzyme USP8 Xiuli Wu, Lily Yen, Lisa K. Irwin, Molecular and Cellular Biology Cell DeathMolecular BiologySignaling PathwayCell RegulationReceptor Tyrosine Kinase	2004	156
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells Demet Candas-Green, Bowen Xie, Jie Huang, Nature Communications	2020	142
Functional Outcome of Low Lumbar Burst Fractures Eric A. Seybold, Colleen Sweeney, Bruce E. Fredrickson, Spine	1999	132
Ligand Discrimination in Signaling through an ErbB4 Receptor Homodimer Colleen Sweeney, Cary Lai, David J. Riese, Journal of Biological Chemistry	2000	131
LRIG1 Is a Novel Negative Regulator of the Met Receptor and Opposes Met and Her2 Synergy David L. Shattuck, Jamie K. Miller, Melanie B. Laederich, Molecular and Cellular Biology Invasive GrowthMet ReceptorCancer BiologyTumor BiologySignaling Pathway	2006	125

Page 1